Atrial support pacing in heart failure: Results from the multicenter PEGASUS CRT trial

Journal of Cardiovascular Electrophysiology

Volumn 23, Issue 12, 2012, Pages 1317-1325

  Martin, David O ^a   Day, John D ^b   Lai, Peter Y ^c   Murphy, Allan L ^d   Nayak, Hemal M ^e   Villareal, Rollo P ^f   Weiner, Stanislav ^g   Kraus, Stacia M ^h   Stolen, Kira Q ⁱ   Gold, Michael R ^j  

^a LERNER RESEARCH INSTITUTE   (United States)

^b INTERMOUNTAIN MEDICAL CENTER   (United States)

^c MEMORIAL MEDICAL CENTER   (United States)

^d Riverside Regional Medical Center   (United States)

^e UNIVERSITY OF CHICAGO MEDICAL CENTER   (United States)

^f Self Regional Healthcare ^*  (United States)

^g Tyler Cardiovascular Consultants   (United States)

^h Integra Group   (United States)

ⁱ Clinical Affairs   (United States)

^j MEDICAL UNIVERSITY OF SOUTH CAROLINA   (United States)

more..

Author keywords

atrial pacing; cardiac resynchronization therapy; heart failure; implantable cardioverter defibrillator; mortality

Indexed keywords

AGED; ARTICLE; CARDIAC RESYNCHRONIZATION THERAPY; CONTROLLED STUDY; DISEASE SEVERITY; FEMALE; FOLLOW UP; HEART FAILURE; HEART LEFT VENTRICLE EJECTION FRACTION; HEART PACING; HUMAN; MAJOR CLINICAL STUDY; MALE; MORTALITY; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL; SELF EVALUATION; SEX DIFFERENCE; SINGLE BLIND PROCEDURE; TREATMENT OUTCOME;

AGED; AUSTRALIA; CARDIAC PACING, ARTIFICIAL; CARDIAC RESYNCHRONIZATION THERAPY; COMORBIDITY; FEMALE; HEART ATRIA; HEART FAILURE; HUMANS; INCIDENCE; MALE; RISK FACTORS; SURVIVAL ANALYSIS; SURVIVAL RATE; TREATMENT OUTCOME; UNITED STATES; VENTRICULAR DYSFUNCTION, LEFT;

EID: 84871201824     PISSN: 10453873     EISSN: 15408167     Source Type: Journal    
DOI: 10.1111/j.1540-8167.2012.02402.x     Document Type: Article

References (36)

1. Abraham WT, Fisher WG, Smith AL, Delurgio DB, Leon AR, Loh E, Kocovic DZ, Packer M, Clavell AL, Hayes DL, Ellestad M, Trupp RJ, Underwood J, Pickering F, Truex C, Mcatee P, Messenger J,: Cardiac resynchronization in chronic heart failure. N Engl J Med 2002; 346: 1845-1853. (Pubitemid 34603028)
2. Cazeau S, Leclercq C, Lavergne T, Walker S, Varma C, Linde C, Garrigue S, Kappenberger L, Haywood GA, Santini M, Bailleul C, Daubert JC,: Effects of multisite biventricular pacing in patients with heart failure and intraventricular conduction delay. N Engl J Med 2001; 344: 873-880. (Pubitemid 32224395)
3. De Marco T, Wolfel E, Feldman AM, Lowes B, Higginbotham MB, Ghali JK, Wagoner L, Kirlin PC, Kennett JD, Goel S, Saxon LA, Boehmer JP, Mann D, Galle E, Ecklund F, Yong P, Bristow MR,: Impact of cardiac resynchronization therapy on exercise performance, functional capacity, and quality of life in systolic heart failure with QRS prolongation: COMPANION trial sub-study. J Card Fail 2008; 14: 9-18.
4. Young JB, Abraham WT, Smith AL, Leon AR, Lieberman R, Wilkoff B, Canby RC, Schroeder JS, Liem LB, Hall S, Wheelan K,: Combined cardiac resynchronization and implantable cardioversion defibrillation in advanced chronic heart failure: The MIRACLE ICD Trial. JAMA 2003; 289: 2685-2694. (Pubitemid 37430139)
5. Bristow MR, Saxon LA, Boehmer J, Krueger S, Kass DA, De Marco T, Carson P, Dicarlo F, Demets D, White BG, Devries DW, Feldman AM,: Cardiac- resynchronization therapy with or without an implantable defibrillator in advanced chronic heart failure. N Engl J Med 2004; 350: 2140-2150.
6. Cleland JG, Daubert JC, Erdmann E, Freemantle N, Gras D, Kappenberger L, Tavazzi L,: The effect of cardiac resynchronization on morbidity and mortality in heart failure. N Engl J Med 2005; 352: 1539-1549. (Pubitemid 40517094)
7. Moss AJ, Hall WJ, Cannom DS, Klein H, Brown MW, Daubert JP, Estes NA, III, Foster E, Greenberg H, Higgins SL, Pfeffer MA, Solomon SD, Wilber D, Zareba W,: Cardiac-resynchronization therapy for the prevention of heart-failure events. N Engl J Med 2009; 361: 1329-1338.
8. Tang AS, Wells GA, Talajic M, Arnold MO, Sheldon R, Connolly S, Hohnloser SH, Nichol G, Birnie DH, Sapp JL, Yee R, Healey JS, Rouleau JL,: Cardiac-resynchronization therapy for mild-to-moderate heart failure. N Engl J Med 2010; 363: 2385-2395.
9. Linde C, Abraham WT, Gold MR, St John Sutton M, Ghio S, Daubert C,: Randomized trial of cardiac resynchronization in mildly symptomatic heart failure patients and in asymptomatic patients with left ventricular dysfunction and previous heart failure symptoms. J Am Coll Cardiol 2008; 52: 1834-1843.
10. Andersen HR, Nielsen JC, Thomsen PE, Thuesen L, Mortensen PT, Vesterlund T, Pedersen AK,: Long-term follow-up of patients from a randomised trial of atrial versus ventricular pacing for sick-sinus syndrome. Lancet 1997; 350: 1210-1216. (Pubitemid 127445094)
11. Kerr CR, Connolly SJ, Abdollah H, Roberts RS, Gent M, Yusuf S, Gillis AM, Tang AS, Talajic M, Klein GJ, Newman DM,: Canadian Trial of Physiological Pacing: Effects of physiological pacing during long-term follow-up. Circulation 2004; 109: 357-362. (Pubitemid 38133904)
12. Lamas GA, Lee KL, Sweeney MO, Silverman R, Leon A, Yee R, Marinchak RA, Flaker G, Schron E, Orav EJ, Hellkamp AS, Greer S, Mcanulty J, Ellenbogen K, Ehlert F, Freedman RA, Estes NA III, Greenspon A, Goldman L,: Ventricular pacing or dual-chamber pacing for sinus-node dysfunction. N Engl J Med 2002; 346: 1854-1862. (Pubitemid 34603029)
13. Gold MR, Niazi I, Giudici M, Leman RB, Sturdivant JL, Kim MH, Yu Y, Ding J, Waggoner AD,: A prospective comparison of AV delay programming methods for hemodynamic optimization during cardiac resynchronization therapy. J Cardiovasc Electrophysiol 2007; 18: 490-496. (Pubitemid 46650333)
14. Martin DO, Stolen KQ, Brown S, Yu Y, Christie C, Doshi SK, Smith JM, Gold MR, Day JD,: Pacing Evaluation-Atrial SUpport Study in Cardiac Resynchronization Therapy (PEGASUS CRT): Design and rationale. Am Heart J 2007; 153: 7-13. (Pubitemid 44880885)
15. Di Pede F, Gasparini G, De Piccoli B, Yu Y, Cuesta F, Raviele A,: Hemodynamic effects of atrial septal pacing in cardiac resynchronization therapy patients. J Cardiovasc Electrophysiol 2005; 16: 1273-1278.
16. Gold MR, Niazi I, Giudici M, Leman RB, Sturdivant JL, Kim MH, Waggoner AD, Ding J, Arcot-Krishnamurthy S, Daum D, Yu Y,: Acute hemodynamic effects of atrial pacing with cardiac resynchronization therapy. J Cardiovasc Electrophysiol 2009; 20: 894-900.
17. Stein KM, Ellenbogen KA, Gold MR, Lemke B, Lozano IF, Mittal S, Spinale FG, Van Eyk JE, Waggoner AD, Meyer TE,: SmartDelay determined AV optimization. A comparison of AV delay methods used in cardiac resynchronization therapy (SMART-AV): Rationale and design. Pacing Clin Electrophysiol 2010; 33: 54-63.
18. Ellenbogen KA, Gold MR, Meyer TE, Fernndez Lozano I, Mittal S, Waggoner AD, Lemke B, Singh JP, Spinale FG, Van Eyk JE, Whitehill J, Weiner S, Bedi M, Rapkin J, Stein KM,: Primary results from the SmartDelay determined AV optimization: A comparison to other AV delay methods used in cardiac resynchronization therapy (SMART-AV) trial: A randomized trial comparing empirical, echocardiography-guided, and algorithmic atrioventricular delay programming in cardiac resynchronization therapy. Circulation 2010; 122: 2660-2668.
19. Packer M,: Proposal for a new clinical end point to evaluate the efficacy of drugs and devices in the treatment of chronic heart failure. J Card Fail 2001; 7: 176-182. (Pubitemid 32554111)
20. Rector TS, Cohn JN,: Assessment of patient outcome with the Minnesota Living with Heart Failure questionnaire: reliability and validity during a randomized, double-blind, placebo-controlled trial of pimobendan. Pimobendan Multicenter Research Group. Am Heart J 1992; 124: 1017-1025.
21. Washburn RA, Smith KW, Jette AM, Janney CA,: The Physical Activity Scale for the Elderly (PASE): Development and evaluation. J Clin Epidemiol 1993; 46: 153-162. (Pubitemid 23092124)
22. Healey JS, Connolly SJ, Gold MR, Israel CW, Van Gelder IC, Capucci A, Lau CP, Fain E, Yang S, Bailleul C, Morillo CA, Carlson M, Themeles E, Kaufman ES, Hohnloser SH,: Subclinical atrial fibrillation and the risk of stroke. N Engl J Med 2012; 366: 120-129.
23. Brubaker PH, Kitzman DW,: Prevalence and management of chronotropic incompetence in heart failure. Curr Cardiol Rep 2007; 9: 229-235. (Pubitemid 46784418)
24. Jorde UP, Vittorio TJ, Kasper ME, Arezzi E, Colombo PC, Goldsmith RL, Ahuja K, Tseng CH, Haas F, Hirsh DS,: Chronotropic incompetence, beta-blockers, and functional capacity in advanced congestive heart failure: Time to pace Eur J Heart Fail 2008; 10: 96-101.
25. Carlson MD, Ip J, Messenger J, Beau S, Kalbfleisch S, Gervais P, Cameron DA, Duran A, Val-Mejias J, Mackall J, Gold M,: A new pacemaker algorithm for the treatment of atrial fibrillation: Results of the Atrial Dynamic Overdrive Pacing Trial (ADOPT). J Am Coll Cardiol 2003; 20;42: 627-633.
26. Pedersen OD, Brendorp B, Kober L, Torp-Pedersen C,: Prevalence, prognostic significance, and treatment of atrial fibrillation in congestive heart failure with particular reference to the DIAMOND-CHF study. Congest Heart Fail 2003; 9: 333-340.
27. Swedberg K, Komajda M, Bohm M, Borer JS, Ford I, Dubost-Brama A, Lerebours G, Tavazzi L,: Ivabradine and outcomes in chronic heart failure (SHIFT): A randomised placebo-controlled study. Lancet 2010; 376: 875-885.
28. Ahmadi-Kashani M, Kessler DJ, Day J, Bunch TJ, Stolen KQ, Brown S, Sbaity S, Olshansky B,: Heart rate predicts outcomes in an implantable cardioverter-defibrillator population. Circulation 2009; 120: 2040-2045.
29. Fox K, Ford I, Steg PG, Tendera M, Robertson M, Ferrari R,: Heart rate as a prognostic risk factor in patients with coronary artery disease and left-ventricular systolic dysfunction (BEAUTIFUL): A subgroup analysis of a randomised controlled trial. Lancet 2008; 372: 817-821.
30. Mensink GB, Hoffmeister H,: The relationship between resting heart rate and all-cause, cardiovascular and cancer mortality. Eur Heart J 1997; 18: 1404-1410. (Pubitemid 27389033)
31. Olshansky B, Day JD, Moore S, Gering L, Rosenbaum M, Mc Guire M, Brown S, Lerew DR,: Is dual-chamber programming inferior to single-chamber programming in an implantable cardioverter-defibrillator? Results of the INTRINSIC RV (Inhibition of Unnecessary RV Pacing With AVSH in ICDs) study. Circulation 2007; 115: 9-16. (Pubitemid 46058606)
32. Wilkoff BL, Kudenchuk PJ, Buxton AE, Sharma A, Cook JR, Bhandari AK, Biehl M, Tomassoni G, Leonen A, Klevan LR, Hallstrom AP,: The DAVID (Dual Chamber and VVI Implantable Defibrillator) II trial. J Am Coll Cardiol 2009; 53: 872-880.
33. Sweeney MO, Ellenbogen KA, Tang AS, Whellan D, Mortensen PT, Giraldi F, Sandler DA, Sherfesee L, Sheldon T,: Atrial pacing or ventricular backup-only pacing in implantable cardioverter-defibrillator patients. Heart Rhythm 2010; 7: 1552-1560.
34. Jorde UP, Vittorio TJ, Kasper ME, Arezzi E, Colombo PC, Goldsmith RL, Ahuja K, Tseng CH, Haas F, Hirsh DS,: Chronotropic incompetence, beta-blockers, and functional capacity in advanced congestive heart failure: Time to pace? Eur J Heart Fail 2008; 10: 96-101.
35. Coman J, Freedman R, Koplan BA, Reeves R, Santucci P, Stolen KQ, Kraus SM, Meyer TE,: A blended sensor restores chronotropic response more favorably than an accelerometer alone in pacemaker patients: The LIFE study results. Pacing Clin Electrophysiol 2008; 31: 1433-1442.
36. Mullens W, Grimm RA, Verga T, Dresing T, Starling RC, Wilkoff BL, Tang WH,: Insights from a cardiac resynchronization optimization clinic as part of a heart failure disease management program. J Am Coll Cardiol 2009; 53: 765-773.